Further studies are warranted to determine the mechanism by which knockdown of S100A4 reduced proliferation, invasion, and chemoresistance of leukemia cells, and rescued the phenotypes induced by treatment with BM-MSC-exos. Here, S100A4 is linked to leukemia.